How to Approach an Increasingly Challenging and Subjective Japanese Pricing Environment L.E.K. Consulting Read more
Related Practice Life Sciences & Pharma Japan remains on balance an attractive pharmaceutical market, with favorable volume dynamics, generally attractive pricing and broad and unfettered market access. 01022024160129
Special Report Medical Equipment Collaborating for a Robust Medical Device Reimbursement Pathway in India April 2, 2024
Special Report Biotech and Pharmaceuticals Scope 3 Emissions: A Strategic Imperative for Pharma Companies March 19, 2024
Article Life Sciences & Pharma Hospital Priorities in China in 2023: Strategic Implications for Pharma Companies December 7, 2023